Tbx1 haploinsufficiency causes brain metabolic and behavioral anomalies in adult mice which are corrected by vitamin B12 treatment
preprint
OA: closed
Abstract
Introduction The brain-related phenotypes observed in 22q11.2 deletion syndrome (22q11.2DS) are highly variable and their origin is poorly understood. Changes in brain metabolism may cause or contribute to the phenotypes, given that many of the deleted genes (approx. 10%) are implicated in metabolic processes, but this is currently unknown. It is clearly important to address this knowledge gap, but in humans, the primary material required for studying brain metabolism is inaccessible. For this reason, we sought to address the issue using two mouse models of 22q11.2DS. Methods We used three independent approaches to investigate brain metabolism in young adult mice, namely, mass spectrometry, nuclear magnetic resonance spectroscopy and transcriptomics. We selected to study primarily Tbx1 single gene mutants because it is the primary candidate disease gene. We then confirmed key findings in the multi-gene deletion mutant Df1/+ . Results We found that Tbx1 mutants have alterations of specific brain metabolites, including methylmalonic acid, which is highly brain-toxic, as well as a more general metabolomic imbalance. We provide transcriptomic evidence of an interaction genotype-vB12 treatment, and behavioural evidence of a response to vB12 treatment, which rescued some of the behavioural anomaly observed in Tbx1 mutants. We conclude that Tbx1 haploinsufficiency causes extensive brain metabolic anomalies, which are partially responsive to vB12 treatment. We suggest that alterations of glutamine-glutamate metabolism and fatty acid metabolism are key components of the metabolic phenotype in these mutants.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
References (51)
- doi:10.1007/s11011-013-9396-0 via crossref
- doi:10.1016/j.bbr.2005.09.005 via crossref
- doi:10.3390/biomedicines11102830 via crossref
- doi:10.1093/hmg/ddt400 via crossref
- doi:10.1007/s10571-022-01236-1 via crossref
- doi:10.1111/acel.13189 via crossref
- doi:10.1002/bies.201600177 via crossref
- doi:10.1093/bioinformatics/bts635 via crossref
- doi:10.1016/0079-6565(95)01017-3 via crossref
- doi:10.3389/fnmol.2021.663598 via crossref
- doi:10.1093/jnen/nlw121 via crossref
- doi:10.3390/ijms19113598 via crossref
- doi:10.3390/nu14142825 via crossref
- doi:10.1096/fj.201800724r via crossref
- doi:10.1016/j.ymgme.2021.10.003 via crossref
- doi:10.1016/j.ymgme.2021.03.017 via crossref
- doi:10.1186/s40842-019-0087-6 via crossref
- doi:10.1038/s41380-021-01318-4 via crossref
- doi:10.1038/s41392-021-00553-z via crossref
- doi:10.1038/s41398-022-01859-4 via crossref
- doi:10.1093/schbul/sby011 via crossref
- doi:10.1093/hmg/ddw267 via crossref
- doi:10.1242/dmm.049415 via crossref
- doi:10.3389/fnins.2015.00469 via crossref
- doi:10.1016/j.neuro.2017.02.005 via crossref
- doi:10.1038/nbt0705-833 via crossref
- doi:10.1038/43903 via crossref
- doi:10.1038/35065105 via crossref
- doi:10.1016/j.biopsych.2023.03.021 via crossref
- doi:10.1111/gbb.12041 via crossref
- doi:10.1152/physiolgenomics.90207.2008 via crossref
- doi:10.1016/j.molmet.2020.02.008 via crossref
- doi:10.1073/pnas.2235651100 via crossref
- doi:10.1016/j.mcn.2008.07.027 via crossref
- doi:10.1093/nar/gks042 via crossref
- doi:10.1038/nrdp.2015.71 via crossref
- doi:10.1016/j.ijdevneu.2010.08.005 via crossref
- doi:10.1002/jnr.23020 via crossref
- doi:10.1074/jbc.m115.672360 via crossref
- doi:10.1371/journal.pone.0091598 via crossref
- doi:10.1073/pnas.0600206103 via crossref
- doi:10.1016/j.imbio.2013.04.008 via crossref
- doi:10.1101/lm.025213.111 via crossref
- doi:10.18632/oncotarget.15053 via crossref
- doi:10.1371/journal.pone.0021685 via crossref
- doi:10.1038/sj.ejhg.5201819 via crossref
- doi:10.1038/s41467-022-31781-8 via crossref
- doi:10.1093/nar/gkab1062 via crossref
- doi:10.1038/s41593-019-0491-3 via crossref
- doi:10.1242/dev.02018 via crossref
- doi:10.1007/s11306-024-02088-0 via crossref
Source provenance
- crossref
- last seen: 2026-07-10T06:41:21.364107+00:00
- europepmc
- last seen: 2026-05-20T01:45:00.602351+00:00
- unpaywall
- last seen: 2026-07-18T06:52:13.688204+00:00